Antiplatelet Therapy In Ischemic Heart Disease oBook

Part I Concepts in Platelet Physiology, Function and Measurement. 1 Platelet physiology and the role of the platelet in ischemic heart disease. Robert F. Storey . 2 Laboratory assessment of platelet function and the effects of antiplatelet agents. Alan D. Michelson, A.L. Frelinger . Part II Pharmacology of Oral Antiplatelet Agents. 3 Cyclooxygenase inhibitors. Nina Chetty Raju, John W. Eikelboom . 4 Aspirin response variability and resistance. Wai-Hong Chen, Daniel I. Simon . 5 P2Y12 inhibitors: Thienopyridines and direct oral inhibitors. Jean-Philippe Collet, Boris Aleil, Christian Gachet, Gilles Montalescot . 6 Thienopyridine response variability and resistance. Udaya S. Tantry, Thomas A. Suarez, Paul A. Gurbel . Part III Pharmacology of Intravenous Antiplatelet Agents. 7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists. James C. Blankenship, Peter B. Berger . 8 Intravenous P2Y12 inhibitors. Steven P. Dunn, Steven R. Steinhubl . 9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents. Nicolai Mejevoi, Anjum Tanwir, Marc Cohen . Part IV Clinical Use of Antiplatelet Agents in Cardiovascular Disease. 10 Antiplatelet therapy in acute coronary syndrome with ST elevation. Christian W. Hamm . 11 Antiplatelet therapy in ST-elevation myocardial infarction. Michelle O'Donoghue, Marc S. Sabatine . 12 Antiplatelet therapy in chronic artery disease. Kamran I. Muhammed, Deepak L. Bhatt . 13 Antiplatelet therapy in peripheral arterial disease. Esther S. Kim, Heather L. Gornik . 14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseases. Larry B. Goldstein . Part V Special Circumstances. 15 Antiplatelet therapy and coronary bypass surgery: risks and benefits. A. Burdess, N.L. Cruden, K.A. Fox . 16 Management of antiplatelet therapy for non-cardiac surgery. Nisheeth Goel, John F. Canales, James J. Ferguson . 17 Antiplatelet therapy and coronary stents. Alanna Coolong, Laura Mauri